
Smith MR, Egerdie B, Hernandez Toriz N, et al, Denosumab HALT Prostate Cancer Study Group. Denosumab in men receiving androgen-deprivation therapy for prostate cancer. N Engl J Med. 2009, 361(8):745
Advertisement
Articles by Smith MR, Egerdie B, Hernandez Toriz N, et al, Denosumab HALT Prostate Cancer Study Group. Denosumab in men receiving androgen-deprivation therapy for prostate cancer. N Engl J Med. 2009, 361(8):745

Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Health Equity & Access Weekly Roundup: November 20, 2026
2
Defining High-Efficacy MS Therapy: Access, Formularies, and Patient Choice
3
FDA Approves First siRNA Therapy for AChR-Positive Myasthenia Gravis
4
FDA Approves Pimicotinib for Symptomatic Tenosynovial Giant Cell Tumor
5